David M Berman sold $811k of IMCR
HEAD OF R&D at Immunocore Holdings plc. 22,732 shares at an average of $35.66, traded Sep 12, 2025, filed Sep 16, 2025.
Score components
- +15RoleOfficer
- +22Trade size$811k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.8%, 3m +7.1%, 6m -9.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001955244-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 12, 2025 | MOption exercise Ordinary Shares10b5-1 | +22,532 | $17.46 | $393k | 22,532 | Sep 16, 2025 |
| Sep 12, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -21,232 | $35.63 | $756k | 1,300 | Sep 16, 2025 |
| Sep 12, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -1,300 | $36.31 | $47k | 0 | Sep 16, 2025 |
| Sep 15, 2025 | MOption exercise Ordinary Shares10b5-1 | +200 | $17.46 | $3,492 | 200 | Sep 16, 2025 |
| Sep 15, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -200 | $35.01 | $7,002 | 0 | Sep 16, 2025 |
| Sep 12, 2025 | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -22,532 | $0.00 | $0 | 198,839 | Sep 16, 2025 |
| Sep 15, 2025 | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -200 | $0.00 | $0 | 198,639 | Sep 16, 2025 |
Related signals
Other insiders at Immunocore Holdings plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | Immunocore Holdings plc | David M Berman HEAD OF R&D | $193k 5,965 shares | -50% | |
| 35Weak | Immunocore Holdings plc | John Goll SVP, FINANCE & CAO | $23k 698 shares | -52% | |
| 50Moderate | Immunocore Holdings plc | Bahija Jallal CHIEF EXECUTIVE OFFICER | $371k 11,474 shares | -48% | |
| 30Weak | Immunocore Holdings plc | Tina Amber St Leger CHIEF HR OFFICER | $32k 1,000 shares | -47% | |
| 25Weak | Immunocore Holdings plc | David M Berman HEAD OF R&D | $1.3M 31,913 shares | -102% | |
| 25Weak | Immunocore Holdings plc | David M Berman HEAD OF R&D | $3.0M 74,925 shares | -108% | |
| 21Weak | Immunocore Holdings plc | David M Berman HEAD OF R&D | $725k 18,120 shares | -18120% | |
| 25Weak | Immunocore Holdings plc | David M Berman HEAD OF R&D | $2.2M 61,849 shares | -100% | |
| 25Weak | Immunocore Holdings plc | David M Berman HEAD OF R&D | $1.8M 50,419 shares | -161% | |
| 50Moderate | IMCRbuy Immunocore Holdings plc | Baker Bros. Advisors LP director | $24M 807,338 shares | +735% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.